Ossur Americas, Inc.

Ossur Americas, Inc., a foreign-owned manufacturer of advanced prosthetic and orthotic devices headquartered in Irvine, California, sells specialized prosthetic limb components, microprocessor-controlled knee and ankle systems, bionic hands, and related orthotic supplies to the Department of Veterans Affairs and Defense Health Agency as a prime contractor on full-and-open federal contracts, with no set-aside participation in its recent federal footprint.

Ossur operates through a single parent entity with one named subsidiary, RCM Enterprise L.L.C. The company competes exclusively without set-aside designations across its federal prime portfolio (2,455 awards, 100% of recent activity), reflecting established competitive standing in specialized medical device procurement. NAICS concentration centers on Surgical Appliance and Supplies Manufacturing (1,201 awards) and Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (631 awards), with PSC-level framing dominated by Medical and Surgical Instruments, Equipment, and Supplies (1,815 awards).

Customer concentration is heavily weighted toward VA networks and the Defense Health Agency. The Department of Veterans Affairs Veterans Integrated Service Network 19 anchors the dollar value with 83 awards worth $28.5 million in combined potential value. The Defense Health Agency ranks second with 74 awards and $23.9 million, followed by the Department of the Army Medical Command (43 awards, $19.3 million). The Department of the Navy Bureau of Medicine and Surgery places third by award count (256 awards) but ninth by dollar value ($9.8 million), illustrating fragmented small-order Navy procurement against concentrated large-value VA and DHA work. The top five customers represent 23% of combined potential value across the entire portfolio.

Ossur holds three named parent vehicles anchoring recent activity. The flagship vehicle is a $265 million single-award Indefinite Delivery Contract with the VA National Acquisition Center awarded February 11, 2025, running through February 10, 2030, covering prosthetic feet, knee units, modular adapters, suspension systems, and liners for distribution across VA prosthetic clinics nationwide, with optional sourcing available to authorized Department of Defense agencies. Task orders under this IDV have generated 23 awards worth $21.2 million. A $5 million single-award Blanket Purchase Agreement with the Defense Health Agency, established November 1, 2023, and running through September 30, 2028, provides comprehensive prosthetic devices, orthotic supplies, and surgical supplies to military treatment facilities; this vehicle has generated 74 awards with a combined potential value of $23.9 million across DHA task orders. A newly awarded $350 thousand single-award Blanket Purchase Agreement with the Defense Health Agency, effective January 14, 2026, through January 13, 2029, provides prosthetic feet and knee units; 43 task orders under related BPA vehicles carry $1.7 million in combined potential value. Additional vehicles include IDCs with the Army Medical Command (W81K0005A0022, 17 task orders, $1 million combined value) and the Navy (W91YTZ09A0087, 13 task orders, $1.8 million combined value).

Activity has grown modestly year over year — 37 awards in 2022 rising to 43 in 2025 — with only 11 awards (combined potential value $485 thousand) reaching ultimate completion in the next twenty-four months, indicating minimal recompete exposure near term. The $265 million VA IDC and the $5 million DHA BPA represent the primary contract vehicles sustaining current volume and represent potential recompete activity post-2028 and post-2029 respectively.

Subcontract activity is negligible: Ossur appears as a supplier to Cardinal Health 200, LLC on three medical and surgical equipment sub-awards spanning 2022 through March 2024, delivering tissue trackers, back support devices, and hemostat agents—supplementary medical supply work outside the core prosthetic portfolio. The subcontract footprint does not materially characterize the vendor's federal posture, which is overwhelmingly prime-centric.

Typical task orders range from $10 thousand to $240 thousand across both VA networks and Defense Health Agency, with firm fixed-price structures and performance split across Ossur facilities in Irvine and Foothill Ranch, Lake Forest, California, and subordinate locations specified by individual Veterans Integrated Service Networks nationwide. The company's established federal contracting history since 2004 and absence of set-aside participation position it as a full-and-open medical device supplier anchored to VA and DoD medical readiness missions rather than as a small business competitor.